Saj Razvi

Saj Razvi is the Founder and Director of Education at the Psychedelic Somatic Institute (PSI) and one of the primary developers of Psychedelic Somatic Interactional Psychotherapy (PSIP), a next-generation, primary consciousness-oriented psychotherapy model. He is a former clinical researcher in the MAPS Phase 2 trial of MDMA-assisted psychotherapy, and has served as faculty at Synthesis. He has also taught PTSD studies at the University of Denver and a PhD course at the University of Copenhagen.

PSIP is a highly relational, highly experiential, embodied therapy model specifically designed to pair with and amplify the healing tendencies of the unconscious mind and body. The modality focuses on maximizing the relational and autonomic healing capacity of psychedelic medicine to treat complex, childhood developmental trauma, utilizing readily accessible medicines such as cannabis and ketamine. Unlike integration-focused or non-relational sitter models, PSIP positions the therapist as an active participant in the client's medicinal consciousness, keeping the process in the human relational realm.

Saj's primary mission is to train clinicians internationally to provide legal, effective psychedelic treatment in private practice settings. PSI's apprenticeship training model is highly experiential and individually focused, requiring therapists to engage in their own process as part of their training. In 2015, Saj was part of a harm reduction effort that was unsuccessful, and he is open about these events as part of his personal and professional story.